Found "Early HTA": 401 results
Momentum for HTA in the Land of a Thousand Hills
In October 2019, the Health Intervention and Technology Assessment Program (HITAP) and the National Health Foundation (NHF), two partners in the Asia Health Technology Assessment (HTA) consortium, were thrilled to take an 8000 km trip to Rwanda to talk all things ‘priority setting’ at a wor
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes.
This study marks the first global eco
The challenges in reimbursement decisions for innovative high-cost drugs: Thailand’s effort to expand drug access
The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide
Concept Note: HTA guideline Project (A stepwise guide for HTA guideline development)
The focus of HTA in this project is HTA for benefit package design. The main output will be a step-by-step guide for HTA methods and/or process guideline development, starting from key considerations in the initial phase to support the set-up of a conducive environment for good HTA, steps to follow
A potential indicator for measuring the success of HTA development
One day, I was perusing the news and I came across an article about the inclusion of five new high-cost drugs in the Thai benefits package. Unbeknownst to me, the Thai Universal Health Coverage (UHC) released a news article in all domestic newspapers informing the public that the Director-General of
China Health Technology Assessment (HTA) Hub
The past few years have seen significant progress in the development of Health Technology Assessment (HTA) in China. The China National Health Development Research Center (CNHDRC), the national focal point for HTA in China, has stepped up efforts to roll out HTA activities in many ways in order to s
Establishment of the Medical Technology Assessment Board (MTAB): Initiating Health Technology Assessment (HTA) in India
Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla
HTAsiaLink 2022: Early Bird Registration is Open!
We are very pleased to announce that the 10th HTAsiaLink Annual Conference is now open for Early Bird Registration and it will be happening in Pattaya, Thailand at Royal Cliff Grand Hotel from 30 Nov – 2 Dec, 2022!
With COVID-19 still hitting hard, treatment and epidemiological p
EVIDENCE APPRAISAL WORKSHOP FOR PHILIPPINE HTA COUNCIL
In the Philippines, use of HTA is not completely new; there have been prior efforts to institutionalize a fair and systematic process of generating policy-relevant evidence to inform coverage of health services, such as listing of drugs in the national formulary and new benefits in the national soci
Empowering Ghana’s Path to Sustainable Healthcare: HITAP’s HTA Capacity Building Workshop in Ghana
On 2nd – 6th October 2023, HITAP hosted a topic selection workshop and communication training for relevant HTA stakeholders in Ghana, with the support of the Access and Delivery Partnership (ADP).
This workshop was held with the aims to increase awareness of health technology ass
10 / Page